Oxidative stress, Nrf2 and keratin up‐regulation associate with Mallory‐Denk body formation in mouse erythropoietic protoporphyria by Singla, Amika et al.
Oxidative Stress, Nrf2 and Keratin Up-regulation
Associate With Mallory-Denk Body Formation in Mouse
Erythropoietic Protoporphyria
Amika Singla,1 David S. Moons,2 Natasha T. Snider,1 Elizabeth R. Wagenmaker,1
V. Bernadene Jayasundera,1 and M. Bishr Omary1,3
Mallory-Denk bodies (MDBs) are hepatocyte inclusions commonly seen in steatohepatitis.
They are induced in mice by feeding 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)
for 12 weeks, which also causes porphyrin accumulation. Erythropoietic protoporphyria
(EPP) is caused by mutations in ferrochelatase (fch), and a fraction of EPP patients
develop liver disease that is phenocopied in Fechm1Pas mutant (fch/fch) mice, which have
an inactivating fch mutation. fch/fch mice develop spontaneous MDBs, but the molecular
factors involved in their formation and whether they relate to DDC-induced MDBs are
unknown. We tested the hypothesis that fch mutation creates a molecular milieu that mimics
experimental drug-induced MDBs. In 13- and 20-week-old fch/fch mice, serum alkaline
phosphatase, alanine aminotransferase, and bile acids were increased. The 13-week-old fch/
fch mice did not develop histologically evident MDBs but manifested biochemical altera-
tions required for MDB formation, including increased transglutaminase-2 and keratin over-
expression, with a greater keratin 8 (K8)-to-keratin 18 (K18) ratio, which are critical for
drug-induced MDB formation. In 20-week-old fch/fch mice, spontaneous MDBs were read-
ily detected histologically and biochemically. Short-term (3-week) DDC feeding markedly
induced MDB formation in 20-week-old fch/fch mice. Under basal conditions, old fch/fch
mice had signiﬁcant alterations in mitochondrial oxidative-stress markers, including
increased protein oxidation, decreased proteasomal activity, reduced adenosine triphosphate
content, and Nrf2 (redox sensitive transcription factor) up-regulation. Nrf2 knockdown in
HepG2 cells down-regulated K8, but not K18. Conclusion: Fch/fch mice develop age-associ-
ated spontaneous MDBs, with a marked propensity for rapid MDB formation upon expo-
sure to DDC, and therefore provide a genetic model for MDB formation. Inclusion
formation in the fch/fch mice involves oxidative stress which, together with Nrf2-mediated
increase in K8, promotes MDB formation. (HEPATOLOGY 2012;56:322-331)
E
rythropoietic protoporphyria (EPP) is an inher-
ited disorder caused by mutations in the ferro-
chelatase (Fch) gene.1,2 More than 40 molecular
defects have been described in Fch gene in EPP
patients.3 Mitochondrial ferrochelatase catalyzes the
insertion of ferrous iron into protoporphyrin IX (PP-
IX), thereby regulating heme biosynthesis.1 Reduced fer-
rochelatase activity in EPP causes excessive accumulation
of PP-IX in red blood cells (RBCs), skin, and liver.4
The disease is characterized by cutaneous photosensitiv-
ity as PP-IX becomes phototoxic upon light exposure.4
Approximately 20% of patients exhibit hepatic manifes-
tations, and 5%-10% progress to endstage liver disease.4
Genetic background has been suggested as a key deter-
minant in the variable clinical symptoms in EPP.3
The Fechm1Pas mutant Balb/c mice (fch/fch) were
previously reported by others.5 These mice harbor a
point mutation in the ferrochelatase gene (resulting in
95% enzymatic activity loss) and suffer from phototox-
icity, hemolytic anemia, and severe hepatic dysfunction.5
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They have elevated levels of serum transaminases, biliru-
bin, and hyperlipidemia.6 Fechm1Pas mice develop bili-
ary and parenchymal hepatic injury as evidenced by the
presence of hepatocyte ballooning, acidophil bodies,
necrosis, and Mallory-Denk bodies (MDBs).7 MDBs
are markers of hepatocellular injury and are seen after
feeding mice for 12 or more weeks with the porphyri-
nogenic compounds griseofulvin or 3,5-diethoxycar-
bonyl-1,4-dihydrocollidine (DDC).8 Interestingly, MDB
formation has not been described in EPP patients and
the characterization and mechanism of MDB formation
in the fch/fch mice has not been addressed.
MDBs are cytoplasmic hyaline inclusions that asso-
ciate with various liver disorders, including alcoholic
and nonalcoholic steatohepatitis.8 In the context of
hepatitis C virus infection, MDB presence is associated
with poor prognosis.9 Biochemically, MDBs are com-
posed primarily of the intermediate ﬁlament proteins
keratins 8 and 18 (K8/K18), ubiquitin (Ub), and the
ubiquitin-binding protein p62.8 The major molecular
processes involved in MDB formation include induc-
tion of K8/K18 expression with an increase in K8-to-
K18 ratio, transglutaminase-2 (TG2) induction, result-
ing in transamidation and keratin crosslinking, and
increased p62 levels.8 TG2 induction concomitant
with an increase in K8-to-K18 ratio leaves excess K8
that is unbound to its obligate binding partner K18,
which is signiﬁcant because K8 appears to be a prefer-
ential TG2 substrate (compared with K18) and TG2-
null mice do not form DDC-induced MDBs.10
Oxidative stress strongly associates with DDC-
induced MDB formation in FVB/N mice (male>female)
due to differences in DDC metabolite formation.11 Sim-
ilarly, C3H mice form far fewer MDBs, as compared
with C57BL mice, due to their ability to maintain levels
and subcellular distribution of the protective enzymes
glyceraldehyde-3-phosphate-dehydrogenase and nucleo-
side-diphosphate-kinase under oxidative stress.12 Addi-
tionally, S-adenosyl methionine prevents the formation
of MDBs in DDC-primed mice by, in part, normalizing
an otherwise compromised proteasomal activity.13
Expression-proﬁle analysis of fch/fch mouse livers showed
major alterations in several oxidative stress-response genes
including glutathione-S-transferase, superoxide dismutase,
and nuclear factor E2 derived 2-like-2 (Nrf2).6 Further,
exogenous treatment of HepG2 cells with protopor-
phyrin increases intracellular H2O2, thereby contributing
to oxidative stress.14
We hypothesized that fch mutation creates a molecular
milieu that mimics experimental drug-induced MDBs.
Upon testing this hypothesis we delineated the genetic sus-
ceptibility of Fechm1Pas mice to spontaneous and drug-
induced MDB formation using various biochemical and
molecular approaches. Our results support the importance
of oxidative stress and Nrf2 in both spontaneous and
DDC-induced MDB formation in Fechm1Pas mice.
Materials and Methods
Antibodies Used. K8 (Troma-I) (Developmental
Studies Hybridoma Bank); glutathione-S-transferase-
M-1 (GSTM1), Ub, and Nrf2 (Santa Cruz Biotech-
nology); mouse/human K8 and K18 (antibody-8592);
mouse/human K18 (antibody-4668)11; p62 (Sigma-
Aldrich); TG2, b-tubulin, human K8 (TS1), and
human K18 (DC10) (Thermo Scientiﬁc).
Animal Experiments. All animal studies were
approved by the Animal Use and Care Committee (Uni-
versity of Michigan). Fechm1Pas mice (Balb/c background;
Jackson Laboratories) were screened using a polymerase
chain reaction (PCR)-based protocol. The 13- and 20-
week-old mice were used to study spontaneous MDB
formation. MDB induction in 20-week-old mice was
done by feeding with LabDiet 5001 (PMI Nutrition
International) containing 0.1% DDC (Sigma-Aldrich) (3
weeks). Age-matched controls were fed a standard mouse
diet. FVB mice were also fed 0.1% DDC (2 to 10 days)
to examine oxidative stress and proteasome inhibition.
Mice were euthanized by CO2 inhalation and intracar-
diac blood was collected for measurement of alkaline
phosphatase (ALP), alanine aminotransaminase (ALT),
and bile acids (BA) (using the Vetscan-vs2 instrument;
Abaxis). Livers were harvested and apportioned for:
hematoxylin-eosin (H&E) staining, biochemical and mo-
lecular analysis, and immunoﬂuorescence staining.
RNA Extraction and Quantitative Real-Time
PCR. Total RNA was extracted utilizing Qiagen
RNeasy kits. TaqMan Reverse Transcriptase kit (Applied
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Biosystems) was used to translate RNA into comple-
mentary DNA (cDNA), which was subjected to real-
time PCR (MyiQ real time PCR detection system, Bio-
rad) and ampliﬁed by Brilliant SYBR green master mix
utilizing gene speciﬁc primers (Supporting Table 1).
Total Lysates, High Salt Extracts (HSE) Prepara-
tion, and Immunoblotting. For total lysates, livers
were homogenized in sodium dodecyl sulfate (SDS)-
containing sample buffer. HSE were prepared as
described15 to obtain keratin-enriched fractions. Equal
protein amounts were loaded (4%-20% gradient SDS-
polyacrylamide gels) and stained by Coomassie blue or
transferred to polyvinylidene-diﬂuoride membranes
and immunoblotted using relevant antibodies.
Histological and Immunoﬂuorescence Studies. H&E-
stained liver sections were assessed for MDBs. For
immunoﬂuorescence studies, liver sections were ﬁxed
in acetone, air-dried, and stained as described.16
MDBs were counted using a 40 lens and seven ﬁelds
were examined per liver specimen.
Mitochondria Isolation, Protein Oxidation Assay,
and Adenosine Triphosphate (ATP) Content. Liver
mitochondria were isolated as described.17 Mitochon-
drial lysates were analyzed for oxidized proteins using
an OxyBlot Protein Oxidation Detection Kit (Milli-
pore). DNP signals were quantiﬁed using ImageJ soft-
ware and expressed as relative intensity values (mean
6 standard error of the mean [SEM]). Mitochondrial
ATP content was measured using an ATP determina-
tion kit (Invitrogen).
Nuclear Extracts and 20S Proteasome Activity. Nu-
clear extracts were prepared using nuclear and cyto-
plasmic extraction reagent kit (Pierce Biotechnology).
Extracts were immunoblotted with anti-Nrf2 antibody.
Liver 20S proteasomal activity was determined using
the 20S proteasome assay kit (Cayman Chemical).
Cell Culture and Transfections. HepG2 hepato-
blastoma cells were transfected with control or Nrf2
small interfering RNA (siRNA) (Santa Cruz Biotech-
nology) using Lipofectamine RNAiMax (Invitrogen)
(48 hours), then used to prepare RNA extracts and
protein lysates.
Statistical Analysis. One-way analysis of variance
(ANOVA) with Dunnett’s post test or unpaired t test
was used for statistical analysis. Differences were con-
sidered signiﬁcant at P < 0.05.
Results
Fechm1Pas Mice Exhibit Spontaneous MDB
Formation. The presence of MDBs was previously
reported in a mouse model of EPP,7 although the
underlying mechanisms are unknown. We carried out
detailed biochemical, serologic, and histological analyses
of the livers of these animals. Initial assessment of 20-
week-old fch/fch mice and their wildtype (wt/wt) and
heterozygous (wt/fch) controls indicated no body weight
differences, whereas the percent liver-to-body weight
ratio was 1.7 to 1.8-fold higher in fch/fch mice relative to
wt/wt and wt/fch mice (Table S2). Serological analysis of
the 20-week-old fch/fch mice revealed increased ALP, ALT,
and BA levels (Fig. 1A), in agreement with previously
reported hepatobiliary injury in fch/fch mice.6,18
Given that an essential component of drug-induced
MDB formation is an up-regulation of keratins with a
K8>K18 ratio and formation of high molecular
weight K8-containing crosslinked species, we examined
if the same features occur in the genetic fch model. As
shown in Fig. 1B, K8 and K18 messenger RNA
(mRNA) levels were increased in fch/fch mice with a
K8-to-K18 ratio of 1.94. Biochemical analysis of fch/
fch livers revealed increased K8/K18 expression (per
mg of liver tissue) as shown by Coomassie staining of
the HSE in Fig. 1C. Immunoblotting showed the pres-
ence of K8-ubiquitin high-molecular-weight complexes
and increased expression of p62 and TG2 in fch/fch
mice (Fig. 1C). These data provide biochemical sup-
port for spontaneous MDB formation in 20-week-old
fch/fch mice. Densitometric analysis showed 2-fold
increase in K8/K18 protein in fch/fch livers (Fig. 1D).
Susceptibility of younger Fechm1Pas mice (13-week-
old) to MDB formation was also examined. Similar to
the 20-week-old mice, 13-week-old fch/fch mice showed
a 1.8-1.9 higher percent liver/body weight (Table S2),
and had elevated levels of ALP, ALT, and BA (Supporting
Fig. S1A). The 13-week-old mice showed K8 and
K18 mRNA induction, with a K8:K18 ratio of 1.25
(Fig. S1B) that is less than the 1.94 ratio seen in the
20-week-old fch/fch mice (Fig. 1B). K8, K18, and TG2
protein levels were increased in 13-week-old fch/fch mice
(Fig. S1C). These mice exhibited K8 dimer formation in
the absence of K8 high molecular weight complexes.
MDB Formation in Fechm1Pas Mice Is Age-
Dependent and Gender-Independent. The above data
suggest that young mice begin to show some of the
initiating events of MDB formation (increased kera-
tins/TG2) but have not yet progressed to mature
MDBs that can be visualized histologically, because
H&E staining revealed the presence of MDBs in 20-
week (Fig. 2A, panels c,d), but not in 13-week-old,
fch/fch mice (Fig. S2, panels c,d). This was further
conﬁrmed biochemically by the limited formation of
high-molecular-weight K8-containing complexes and
lack of induction of p62, another key constituent of
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MDBs (Fig. 2B). Immunoﬂuorescence staining revealed
prominent keratin and ubiquitin colocalized deposits in
20-week-old (Fig. 3, panels c,d) but not in 13-week-old
fch/fch livers (Fig. S3), supporting our histological and
biochemical ﬁndings. Keratin and ubiquitin staining for
20-week-old livers is shown in Fig. S4. Taken together,
these data indicate that MDB formation in Fechm1Pas
mice occurs in an age-dependent manner.
Given that male FVB/N mice are more susceptible
to drug-induced MDB formation,11 potential gender
differences in spontaneous MDB formation were ana-
lyzed. Notably, Fechm1Pas mice (Balb/c background)
did not show a gender-based (M>F) predilection to
MDB formation which was conﬁrmed using biochemi-
cal (Fig. 2C) and histological (not shown) means.
Fechm1Pas Mice Have Increased Susceptibility to
Drug-Induced MDBs. The possibility that the under-
lying genetic predisposition of spontaneous MDBs ren-
ders Fechm1Pas mice more susceptible to drug-induced
MDBs was tested using a modiﬁed, 3-week DDC
feeding protocol, which is signiﬁcantly shorter than
the standard 12-16 weeks.8 Short-term DDC feeding
markedly induced K8/K18 mRNA in all three geno-
types relative to their non-DDC-fed controls (Fig. 4A).
Biochemically, wt/fch mice respond by a dramatic up-
regulation of K8 and K18 (compare Fig. 4B, lanes 2þ3
with 5þ6), which parallels increased K8 crosslinking
(Fig. 4B). There was a signiﬁcant increase in MDB
numbers in wt/fch mice (13.2 6 0.4) after DDC feed-
ing, whereas MDB numbers was 16.7 6 1.9 in non-
DDC-fed fch/fch mice and 19.2 6 2.4 in DDC-fed
fch/fch mice. There was also an increase in TG2 levels
in DDC-fed mice (Fig. 4B). Histological analysis con-
ﬁrmed the increase in DDC-induced MDBs in wt/fch
and fch/fch mice (Fig. 5). These data indicate that the
Fechm1Pas mice have a markedly enhanced propensity to
form drug-induced MDBs.
Mitochondrial Oxidative Stress Is Altered in
Fechm1Pas Mice. Prior expression-proﬁle analysis of liv-
ers from Fechm1Pas mice revealed alterations in genes
involving heme metabolism, inﬂammation, and oxida-
tive stress.6 Because mitochondria play an important
role in reactive oxygen species generation, we examined
several mitochondrial oxidative stress markers. fch/fch
livers had increased protein oxidized by-products relative
to wt/wt and wt/fch livers (Fig. 6A). Additionally, gluta-
thione-S-transferase-mu-1 (GSTM1, induced during
oxidative stress19) was markedly enhanced under basal
conditions in the fch/fch livers (Fig. 6B, compare lanes
9þ10 with 1þ2 or 5þ6).
Oxidative damage to mitochondria can lead to
injury through ATP depletion. Notably, there was a
signiﬁcant decrease in ATP content in fch/fch livers
relative to wt/wt and wt/fch livers, and DDC feeding
led to further reduction of ATP, particularly in wt/fch
and fch/fch livers (Fig. 6C). Given that increased oxi-
dative stress has been shown to decrease proteasomal
activity, which is associated with MDB formation,13,20
we tested and observed a 2-fold inhibition of the 20S
proteasomal activity in the fch/fch mice and also in
Fig. 1. Serum and biochemical analysis of
livers of 20-week-old mice. (A) Serum was
collected from 20-week-old wt/wt, wt/fch, and
fch/fch mice and used to measure ALT (U/L),
ALP (U/L), and BA (lmol/L) levels. N ¼ 3/
group and *P < 0.05 compared with wt/wt.
(B) K8 and K18 mRNA levels in indicated ge-
notypes were quantiﬁed using real-time PCR.
The ratio of K8 to K18 mRNA in fch/fch is
1.94. *P < 0.05 compared with wt/wt. (C)
Top panel (a) Coomassie stain for HSEs show-
ing increased K8 and K18 expression in fch/
fch mice and (b) immunoblots for K8, ubiqui-
tin, and p62 of the HSEs (prepared using
100 mg of liver tissue, equal fractions were
loaded). (c) Total liver lysates were used to
examine TG2 levels (b-tubulin as a loading
control). Each lane corresponds to a separate
liver fraction. (D) Quantiﬁcation of K8/K18
protein bands (from panel Ca) by densitomet-
ric scanning using ImageJ software.
HEPATOLOGY, Vol. 56, No. 1, 2012 SINGLA ET AL. 325
the DDC fed wt/wt, wt/fch, and fch/fch mice (Fig.
6D). These results suggest that oxidative stress in fch/
fch mice decreases proteasomal activity.
Fechm1Pas Mice Show Increased Expression of
Nrf2. Nuclear factor E2 derived 2-like-2 (Nrf2) is a
redox sensitive transcription factor expressed in the
liver.21 Nrf2 regulates multiple antioxidant pathways21
and its mRNA is up-regulated in Fechm1Pas mice based
on unvalidated microarray studies.6 Therefore, mRNA
levels and nuclear protein expression of Nrf2 in con-
trol and DDC-fed wt/wt, wt/fch, and fch/fch livers
were analyzed. There was increased Nrf2 liver mRNA
Fig. 3. Analysis of MDB formation using im-
munoﬂuorescence staining. Liver sections from
20-week-old mice of the indicated genotypes
were double stained using K8/K18 (red) and
Ub (green) antibodies. Nuclei are shown in
blue. MDBs (yellow dots due to colocalization
of two epitopes) were noted using 40 lens
in the fch/fch livers and are highlighted by
white arrows (panel c). Panel d represents the
higher magniﬁcation of the boxed area in
panel c. Scale bar ¼ 20 lm.
Fig. 2. fch/fch mice exhibit age-
dependent and gender-independent
formation of MDBs. (A) H&E stain-
ing of livers from 20-week-old ani-
mals. Panel c represents the image
taken using a 40 objective,
whereas panel d is 100 image of
20-week-old fch/fch livers. Black
arrows (panels c,d) highlight the
MDBs in the 20-week-old fch/fch
mice (scale bar ¼ 50 lm). (B) K8
crosslinking was visualized by im-
munoblotting HSEs from 13- and
20-week-old fch/fch mice. (C)
HSEs from 20-week-old male and
female mice were immunoblotted
for K8. For panel B, each lane cor-
responds to separate liver fractions.
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expression (3 fold) in fch/fch relative to wt/wt mice
(Fig. 7A). Short-term DDC feeding induced liver
Nrf2 mRNA levels in all mice. Consistent with the
mRNA ﬁndings, control and DDC-fed fch/fch mice
had signiﬁcant induction in nuclear Nrf2 protein (Fig.
7B). These results indicate Nrf2 up-regulation in con-
trol and DDC-fed fch/fch mice, likely in response to
oxidative stress. To further examine the sequence of
events, FVB mice were fed DDC for 2-10 days. Anal-
ysis of the DDC-fed livers showed an increase in Nrf2
mRNA and protein expression after 5 days of DDC
feeding (Fig. S5A,B). However, there was no inhibition
in proteasome activity in 2-day and 5-day DDC-fed
livers (Fig. S5C), suggesting that there is another
mechanism involved in increasing Nrf2 expression.
Further, we examined the mitochondrial oxidized pro-
teins, and Oxyblot analysis (Fig. S5D) showed an
increase in oxidized protein by-products in 5-day
DDC-fed mice, suggesting that oxidative stress is
upstream of proteasome inhibition. Nrf2 protein levels
were greatly stabilized in M132-treated HepG2 cells,
suggesting that proteasome inhibition also help stabi-
lize Nrf2 protein (Fig. S5E).
Nrf2 Regulates K8 but Not K18 Expression. Nrf2
was shown previously to regulate keratin-16 (K16)
gene expression in human keratinocytes.22 Therefore,
we examined the effect of Nrf2 on K8 and K18
expression in HepG2 cells using siRNA knockdown.
Nrf2 siRNA but not control siRNA signiﬁcantly
inhibited K8 but not K18 mRNA and protein
Fig. 5. H&E staining of liver sections from
control and DDC-fed fch/fch and wt/fch mice.
H&E staining was performed to examine the
MDBs in livers of DDC-fed mice. MDBs are
marked using black arrows (scale bar ¼ 50
lm). Panels a-c are 40 images and d-f are
the 100 images.
Fig. 4. Short-term DDC feeding of fch/fch
mice induces prominent MDB formation. The
20-week-old wt/wt, wt/fch, and fch/fch mice
were fed DDC for 3 weeks. (A) RNA (extracted
from the control and DDC livers) was sub-
jected to real-time PCR to examine K8 and
K18 mRNA levels. N ¼ 3, *P < 0.05 versus
wt/wt. (B) HSEs from the control and DDC liv-
ers were (a) stained by Coomassie blue or
(b) immunoblotted using antibodies to K8 or
TG2. Each lane corresponds to a separate
liver fraction.
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expression (Fig. 7C,D). These ﬁndings suggest that the
K8 gene is a target for Nrf2.
Discussion
Relevance of MDBs to EPP in Humans and
Mouse Models of EPP. Porphyrias are inherited meta-
bolic disorders that occur due to defects in the heme
biosynthetic pathway, and are divided into acute and
nonacute porphyrias.23 EPP is a nonacute porphyria
caused by mutation in the Fch gene. Two mouse mod-
els of EPP have been described to date. The ﬁrst
model was generated by an Fch exon deletion which
led to embryo-lethality of the homozygous mice,
whereas heterozygous mice developed mild protopor-
phyria without liver disease.24 The second model
(Fechm1Pas) was generated by inducing a point muta-
tion in the Fch gene,5 which has been a valuable ani-
mal model for EPP because it mimics the most severe
hepatic forms of the human disease.
The presence of MDBs has been described in the
Fechm1Pas mouse strain and also in the griseofulvin-induced
Fig. 6. Comparison of oxidative stress
markers in livers of 20-week-old fch/fch ver-
sus controls. (A) Protein oxidation was meas-
ured as described in Materials and Methods.
(B) Lysates of livers from the indicated geno-
types (DDC-fed or normal chow) were blotted
with GSTM1 antibody. For panels A and B,
each of the lanes corresponds to liver prepa-
rations from independent mice. (C) Mitochon-
drial ATP content was measured in the livers
isolated from control and DDC-fed mice. (D)
20S proteasomal activity was measured in
liver homogenates from control and DDC-
treated mice. N ¼ 3, *P < 0.05 compared
versus wt/wt.
Fig. 7. K8 is a target gene for Nrf2. (A) RNA
was isolated from the livers of control and
DDC-fed mice and quantiﬁed for Nrf2 mRNA.
(B) Immunoblot analysis (using anti-Nrf2 anti-
body) of nuclear extracts from control and
DDC-fed livers (Coomassie stain is included
as a loading control). Representative blot of
three independent experiments is shown, and
quantiﬁcation was done from the three experi-
ments (*P < 0.05 versus wt/wt). (C) HepG2
cells were transfected with control and Nrf2
siRNA. Real-time PCR was utilized to examine
K8 and K18 mRNA levels. (D) Total lysates
were immunoblotted using K8, K18, and Nrf2
antibodies. b-Actin served as a loading con-
trol. For all the experiments. N ¼ 3, *P <
0.05.
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mouse model of EPP.7,25 However, MDBs have not
been reported in EPP patients. It should be noted that
MDBs are visualized in clinical contexts using histologi-
cal approaches (e.g., H&E staining), which lack sensitiv-
ity for detecting small and early MDBs.16 It is possible
that some patients with EPP may form MDBs if sensi-
tive methods are employed for their detection, and
if indeed found then the genetic background of an
individual may be a contributing factor. For example,
Hispanics appear to be more predisposed to MDB forma-
tion,9,26 and clear differences in MDB susceptibility are
also noted in different mouse strains.12,16 Other potential
factors that may contribute to the apparent absence of
MDBs in EPP patients (versus the animal models) may
be related to differences in porphyrin metabolites across
species. In this context, the contribution of porphyria per
se to MDB formation is unclear. Certainly, porphyrin
accumulation leads to oxidative stress,14 although other
factors are likely important. The range of accumulation
of protoporphyrin-IX (PP-IX) in DDC-fed male (550
nmol/g protein) and female (1,900 nmol/g protein)
mice11 is similar to the porphyria in the fch/fch mice
(1,000-5,000 nmol/g protein6,27). By comparison,
patients with EPP have PP-IX levels in the range of
3,000-8,000 nmol/g tissue,1 although the genetic modi-
ﬁers that result in severe human liver disease in the 5%-
10% of affected EPP patients are not known.
fch/fch Mice Manifest Spontaneous MDB
Accumulation and Enhanced Susceptibility to Drug-
Induced MDB Formation. Our ﬁndings herein char-
acterize the formation of spontaneous and DDC-induced
MDBs in fch/fch mice and showed that MDBs formation
in these mice is age-dependent but gender-independent.
The lack of gender-dependency in this model, in contrast
to the FVB/N drug-induced model, may be due to
genetic mouse strain differences (Balb/c versus FVB/N)
or may be related to the increased porphyria that might
overcome genetic gender-related inﬂuences.
The enhanced susceptibility to drug-induced MDB
formation, even in the heterozygous wt/fch mice, ren-
ders these mice very useful for studying MDBs given
that MDBs can be induced in these mice within 3
weeks as compared with the standard 12 to 16-week
DDC regimen. Hence, these mice are even more sus-
ceptible to MDB formation when compared with
another genetic model, which is mice that overexpress
K8 (which develop MDBs within 6 weeks of DDC
exposure).28 The spontaneous formation of MDBs in
fch/fch mice is also reminiscent of their formation in
the K8-overexpressor mice and in the K18-null mice
upon aging (both have a K8>K18 ratio).28,29
Oxidative Stress, Proteasome Function, and Nrf2
in MDB Formation in fch/fch Mice. Oxidative stress
plays a major role in several protein aggregation disor-
ders.30,31 It is also involved in MDB formation in FVB/
N and K8-overexpressing mice in response to DDC feed-
ing.11 Our ﬁndings demonstrate a role for oxidative stress
in MDB formation in fch/fch mice, and support previ-
ously reported alterations in oxidative stress genes in fch/
fch mice and in EPP patients utilizing microarray analy-
sis.3,6 In addition, griseofulvin-induced EPP in mice
results in ultrastructural changes in liver mitochondria,
accumulation of large amounts of protoporphyrin, and
low-energy coupling in mitochondria, which suggest
blunting of mitochondrial function.32 Moreover, treat-
ment of HepG2 cells with protoporphyrin in the absence
of light increases intracellular H2O2 levels, which sup-
ports the role of protoporphyrin in causing oxidative
stress.14 Our data are consistent with the presence of mi-
tochondrial oxidative stress in the fch/fch livers, as dem-
onstrated by decreased mitochondrial ATP and increased
liver oxidized proteins (Fig. 6; Fig. S5), possibly due to
accumulation of protoporphyrin deposits.
Fig. 8. Schematic of the crosstalk between oxidative stress and
MDB formation in the context of Fech mutation. A defect in ferrochela-
tase leads to accumulation of protoporphyrin-IX (PP-IX) in liver mito-
chondria, which results in increased mitochondrial oxidative stress and
reduced ATP content. The increase in oxidative stress leads to protea-
some inhibition, decreased Nrf2 degradation, with subsequent nuclear
translocation of Nrf2. Nuclear Nrf2 then binds to the antioxidant
response element (ARE) of the K8 gene and increases K8 mRNA,
among additional transcriptional regulatory events. The increase in K8,
TG2, and p62 promotes MDB formation. [Color ﬁgure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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The time course of DDC feeding to FVB animals
demonstrated that oxidative stress is upstream of pro-
teasome inhibition and correlates with the increase
Nrf2 expression, which becomes further magniﬁed
upon proteasome inhibition. Therefore, the observed
50% decrease in proteasome function in fch/fch mice
under basal conditions are likely intimately linked to
the increased oxidative milieu in the livers of these ani-
mals. Reduction in mitochondrial ATP content impairs
proteasomal activity, which in turn leads to mitochon-
drial dysfunction in various disease states.20 Furthermore,
proteasome inhibition in vivo accelerates MDB forma-
tion from 6 weeks to 2 weeks in K8-overexpressing
mice,33 and a decrease in proteasome activity became
normalized upon S-adenosylmethionine administration
to DDC-fed mice in a short-term rechallenge model.13
Nrf2 is a redox-sensitive transcription factor that pro-
tects cells from oxidative stress.21 It is sequestered in the
cytoplasm by Keap-1 (Kelch-like ECH associating pro-
tein 1) under nonstress conditions and is targeted for
ubiquitination and proteasomal degradation.21 During
stress, Nrf2 escapes Keap-1-mediated repression and
translocates to the nucleus to up-regulate various genes
such as glutathione-S-transferases and heme oxygenase-
1.21 Notably, the phytochemical sulforaphane, which
activates Nrf2, up-regulates epidermal keratins K16 and
K1734 and Nrf2 up-regulates K16 in human keratino-
cytes.22 Furthermore, autophagy deﬁciency and up-regu-
lation of p62 are known to stabilize Nrf2, resulting in
activation of Nrf2 target genes.35 Our ﬁndings showed a
decrease of K8, but not K18, mRNA and protein upon
Nrf2 knockdown in HepG2 cells, and also showed Nrf2
nuclear accumulation in fch/fch mice under basal condi-
tions and in fch/fch, wt/fch, and wt/wt livers after expo-
sure to DDC (Fig. 7). Furthermore, sequence analysis of
the 50-proximal promoter region of K8 and K18 revealed
the presence of Nrf2 consensus binding sequence (not
shown). This was consistent with the study showing the
Nrf2 binding sites on K16 promoter region.22 Based on
the ﬁndings herein, and the established importance of
K8 in MDB formation8 and of PPIX in oxidative
stress,14 we propose a model (Fig. 8) whereby accumula-
tion of PPIX leads to increased mitochondrial oxidative
stress that inhibits the Keap-1-mediated Nrf2 degrada-
tion, thereby resulting in translocation of Nrf2 to nu-
cleus and up-regulation of K8 and other target genes.
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